Berkeley Lights Inc (BLI) is a biotechnology company that develops and commercializes cell analysis and engineering platforms. Its platforms enable the rapid selection, characterization, and modification of cells to improve the discovery and development of new therapies. The company's proprietary Beacon and Lightning systems integrate optics, microfluidics, and automation to enable highly efficient, high-throughput workflows. Berkeley Lights' customers include pharmaceutical, biotechnology, and academic institutions, and the company is headquartered in Emeryville, California. As of September 2021, the company had a market capitalization of approximately $5.15 billion.
Berkeley Lights Inc (BLI) is a biotechnology company that develops and commercializes cell analysis and engineering platforms. Its platforms enable the rapid selection, characterization, and modification of cells to improve the discovery and development of new therapies. The company's proprietary Beacon and Lightning systems integrate optics, microfluidics, and automation to enable highly efficient, high-throughput workflows. Berkeley Lights' customers include pharmaceutical, biotechnology, and academic institutions, and the company is headquartered in Emeryville, California. As of September 2021, the company had a market capitalization of approximately $5.15 billion.